Larik Muhammad Omar, Ahmed Ayesha, Shahid Abdul Rehman, Irfan Hamza, Irfan Areeka, Jibran Muhammad
Department of Medicine, Dow International Medical College, Karachi, Pakistan.
Department of Medicine, King Edward Medical University/Mayo Hospital, Lahore, Pakistan.
Clin Med Insights Cardiol. 2024 Aug 30;18:11795468241274588. doi: 10.1177/11795468241274588. eCollection 2024.
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is the preferred strategy for treating obstructive coronary artery disease. Existing literature suggests the worsening of clinical outcomes in patients with previous coronary artery bypass grafting (CABG) history. In light of this, a comprehensive systematic review and meta-analysis was performed.
Databases including PubMed, Cochrane Library, and ScienceDirect were utilized for the inclusive systematic search dating from inception to September 01, 2023. The risk of bias assessment was performed using the Newcastle-Ottawa scale for cohort studies, and the Cochrane Risk of Bias Tool for randomized controlled trials.
Ultimately, there were 16 eligible studies pooled together, involving a total of 250 684 patients, including 231 552 CABG-naïve patients, and 19 132 patients with a prior history of CABG. Overall, patients with CABG history were associated with significantly greater short-term mortality ( = .004), long-term mortality ( = .005), myocardial infarction ( < .00001), major adverse cardiovascular events ( = .0001), and procedural perforation ( < .00001). Contrastingly, CABG-naïve patients were associated with significantly greater risk of cardiac tamponade ( = .02) and repeat CABG ( = .03). No significant differences in stroke, bleeding, revascularization, or repeat PCI were observed.
Comparatively worsened clinical outcomes were observed, as patients with prior CABG history typically exhibit complex coronary anatomy, and have higher rates of comorbidities in comparison to their CABG-naïve counterparts. The refinement of current procedural and surgical techniques, in conjunction with continued research endeavors, are needed in order to effectively address this trend.
经皮冠状动脉介入治疗(PCI),也称为冠状动脉成形术,是治疗阻塞性冠状动脉疾病的首选策略。现有文献表明,有冠状动脉旁路移植术(CABG)病史的患者临床结局会恶化。鉴于此,进行了一项全面的系统评价和荟萃分析。
利用包括PubMed、Cochrane图书馆和ScienceDirect在内的数据库进行全面的系统检索,检索时间从数据库建立至2023年9月1日。使用纽卡斯尔-渥太华量表对队列研究进行偏倚风险评估,使用Cochrane偏倚风险工具对随机对照试验进行评估。
最终,共纳入16项符合条件的研究,涉及250684例患者,其中包括231552例未接受过CABG的患者和19132例有CABG病史的患者。总体而言,有CABG病史的患者短期死亡率(P = 0.004)、长期死亡率(P = 0.005)、心肌梗死(P < 0.00001)、主要不良心血管事件(P = 0.0001)和手术穿孔(P < 0.00001)的发生率显著更高。相比之下,未接受过CABG的患者发生心脏压塞(P = 0.02)和再次CABG(P = 0.03)的风险显著更高。在中风、出血、血运重建或再次PCI方面未观察到显著差异。
观察到有CABG病史的患者临床结局相对更差,因为与未接受过CABG的患者相比,有CABG病史的患者通常表现出复杂的冠状动脉解剖结构,且合并症发生率更高。需要改进当前的手术和外科技术,并持续开展研究工作,以有效应对这一趋势。